By Syaibatulhamdi from Pixabay
Following years of research study and advancement in partnership with world class academic and clinical organizations, Avicanna is happy to be introducing RHO Phyto, a complete formulary of innovative medical marijuana products, for clients and the medical community in Canada. Following the Micro Drop oils, Avicanna expects to introduce 2 sophisticated sublingual spray formulas in the upcoming weeks. The RHO Phyto product line includes oil drops, sublingual sprays, pills and topicals with varying ratios of CBD and THC. The RHO Phyto products are designed to resolve a series of medical conditions that may require various rates of relief. For example, the “Fast Act” sublingual sprays offer a faster start of effects than the “Simple Dosage” capsules and “Micro Drop” oils. To guarantee batch-to-batch consistency and premium products, these formulas are made under Great Manufacturing Practices (“GMP“) in collaboration with MediPharm Labs Inc. and GMP-level analytical testing is carried out by Sigma Analytical Solutions Inc. All RHO Phyto items will be tracked using blockchain technology established by TruTrace Technologies Inc. to manage, track and trace each step of the supply chain.
Aras Azadian, CEO of Avicanna commented, “Our company believe that our RHO Phyto formulary is designed to resolve many spaces in the existing medical cannabis framework with respect to patient needs and provide a chance to bring in new prescribers and patients to medical marijuana options. The intro of a strictly medical line of items, backed by extensive research, pre-clinical information, GMP manufacturing and provided by Buyers, has the opportunity to set a brand-new requirement of care and develop RHO Phyto as the leading medical line of product in the medical cannabis market.”
With the client in mind, RHO Phyto Micro Drop oils are formulated with enhanced absorption, prolonged stability, and consistency. The blood orange flavoured Micro Drop oil 1.6 CBD – 0.06 THC and Micro Drop oil 0.6 CBD– 0.16 THC are available in a 25:1 and 4:1 CBD to THC ratio, respectively. The item name includes the amount in milligrams (mg) of CBD and THC that is provided per dosage. In-depth standards about dosing and titration for Healthcare Practitioners (“HCPs“) and patients is available on the RHO Phyto site at www.rhophyto.com, along with on the Avicanna Academy website at https://www.avicanna.com/the-avicanna-academy/, in addition to additional item info, item guidelines for patients, and regularly asked concerns. As a part of Avicanna’s commercialization method, the Business will be offering education and training for HCPs, clients, and medical institutions about medical marijuana and the RHO Phyto line of product. Educational materials can be discovered on the Avicanna Academy website at https://www.avicanna.com/the-avicanna-academy/, including a recording of Avicanna’s 3 rd annual symposium that was hosted essentially in partnership with Consumers on July 21 st and was live-streamed by over 1,000 individuals.
The Business has also re-branded and re-launched its subsidiary, My Cannabis Clinic (formerly called MyCannabis), which specializes in assisting clients to get to medical marijuana and cannabinoid-based products for medical usage. My Cannabis Center is committed to providing HCPs and clients with the support and education needed for medical cannabis usage. My Cannabis Clinic believes in offering quality care and education to their patients on the considerations and advantages that medical cannabis has to provide. Information about My Cannabis Clinic can be discovered at
https://mycannabisclinic.org/.About Avicanna Inc.Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research study, development and commercialization of plant-derived cannabinoid-based items for the worldwide customer, medical, and pharmaceutical market segments.
Avicanna is a recognized leader in cannabinoid research study and advancement, which it mostly carries out at its R&D head office in the Johnson & & Johnson Development Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have established and advertised a number of market leading line of product, including:
- Pura H&W: an advanced and medically tested line of CBD consumer dermacosmetic products; and,
- RHO Phyto: an advanced line of medical marijuana items consisting of varying ratios of CBD and THC presently offered nation-wide across Canada in partnership with Medical Cannabis by Shoppers ™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the very first strictly medical formulary of advanced “Cannabis 2.0” products, consisting of oils, sprays, pills, creams, and gels, all established with scientific rigour, made under GMP requirements and supported by pre-clinical information.
With continuous scientific trials on its dermacosmetic (Pura H&W), medical marijuana (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s commitment to looking into the crucial function that cannabinoids play in a progressively wider scope of products has been at the core of the Business’s vision since its beginning. In addition, Avicanna’s dedication to education is shown through its annual medical seminar, the Avicanna Academy instructional platform, and the My Cannabis Center patient program through its subsidiary company.
Avicanna handles its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, affordable, and industrial scale subsidiaries, Avicanna cultivates, processes, and advertises a series of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical active ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of uncommon cultivars for industrial production together with feminized seeds for worldwide export. In June 2020, Avicanna made history with a delivery of hemp seeds to the United States of America by completing the very first export of hemp seeds from Colombia.
About My Marijuana Clinic
My Cannabis Center, a wholly-owned subsidiary of Avicanna, is an online health care platform that concentrates on supplying residents of Canada with access to cannabis and cannabinoid products for medical use. My Marijuana Center is committed to supplying its clients with support and education needed while using medical marijuana. My Cannabis Center believes in supplying quality care and education to our clients about the medical benefits that cannabis needs to offer.Stay Connected Cautionary Note Concerning Forward-Looking Details and Statements This news release consists of”positive info”within the meaning of appropriate securities laws. Forward-looking details included in this news release might be determined by the usage of words such as,”may “,”would”,” might “,”will”,”most likely”,” anticipate”,”expect”, “believe, “intend “, “strategy”, “forecast”, “project “, “price quote “, “outlook “and other comparable expressions, and includes declarations with respect to the ability of the Company to release the RHO Phyto sublingual spray at Shoppers, the ability of the RHO Phyto products to attend to a variety of medical conditions that may need numerous rates of relief, the ability of the RHO Phyto formulary to address many spaces in the existing medical marijuana framework as well as patient needs, the capability of the Company to perform medical trials using various RHO Phyto items in partnership with numerous leading Canadian medical institutions and the possibility of such clinical trials examining the security, tolerability and efficacy of the RHO Phyto products for treating a range conditions such as chronic pain, inflammatory bowel disorder, and their associated co-morbidities. Forward-looking details is not a guarantee of future performance and is based upon a number of price quotes and presumptions of management due to management’s experience and understanding of trends, existing conditions and anticipated developments, along with other factors relevant in the circumstances, including assumptions in respect of existing and future market conditions, the existing and future regulative environment; and the availability of licenses, approvals and permits.Although the Company believes that the expectations and presumptions on which such forward-looking info is based are reasonable, excessive reliance ought to not be put on the forward-looking details since the Company can give no assurance that they will prove to be appropriate. Actual results and developments may differ materially from those considered by these declarations. Positive information goes through a range of threats and uncertainties that could trigger real occasions or results to vary materially from those predicted in the forward-looking info. Such threats and unpredictabilities consist of, but are not restricted to current and future market conditions, including the market cost of the common shares of the Business, and the threat factors set out in the Business’s annual details type dated April 15, 2020, filed with the Canadian securities regulators and readily available under the Company’s profile on SEDAR at www.sedar.com. The statements in this press release are made as of the date of this release. The Company disclaims any
intent or responsibility to upgrade any forward-looking info, whether as a result of brand-new information, future occasions or outcomes or otherwise, other than as needed by relevant securities laws.SOURCE Avicanna Inc.< img alt src= "https://rt.newswire.ca/rt.gif?NewsItemId=C5339&Transmission_Id=202008120745CANADANWCANADAPR_C5339&DateId=20200812"> For additional info: about Avicanna&, see www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President
by e-mail at [e-mail safeguarded] Related Links< a title="Link to http://avicanna.com"href="http://avicanna.com"class="linkOnClick"rel="nofollow" target= "_ blank">
Released at Wed, 12 Aug 2020 11:48:45 +0000